According to Zydus Lifesciences's latest financial reports the company's total assets are $3.13 B. A companyโs total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.
Year | Total assets | Change |
---|---|---|
2023-03-31 | $3.13 B | -14.42% |
2022-03-31 | $3.66 B | 12.72% |
2021-03-31 | $3.25 B | 3.52% |
2020-03-31 | $3.14 B | -7.12% |
2019-03-31 | $3.38 B | 21.89% |
2018-03-31 | $2.77 B | 18.11% |
2017-03-31 | $2.34 B | 55.66% |
2016-03-31 | $1.50 B | 4.28% |
2015-03-31 | $1.44 B | 8.44% |
2014-03-31 | $1.33 B | -1.74% |
2013-03-31 | $1.35 B | 8.31% |
2012-03-31 | $1.25 B | 22.49% |
2011-03-31 | $1.02 B | 22.69% |
2010-03-31 | $0.83 B | 25.25% |
2009-03-31 | $0.66 B | 3.41% |
2008-03-31 | $0.64 B | 38.3% |
2007-03-31 | $0.46 B | 31.87% |
2006-03-31 | $0.35 B | 13.26% |
2005-03-31 | $0.31 B | 0.69% |
2004-03-31 | $0.30 B |